Lentiviral vectors are considered as powerful therapeutic tools due to their tendency to efficiently target non-dividing and differentiated cells, such as neurons or dendritic cells. As such, these vectors are broadly used in a multitude of in vivo and ex vivo clinical applications for the treatment of hematological and neurological disorders, such as β-thalassemia, sickle cell disease, gene therapy based on enzyme replacement and the delivery of neurotrophic factors for neurodegenerative disease.
As a CRO, CRDMO, Esco Aster provides viral vector production services in varying grades--research/preclinical, clinical, and commercial, respectively. Choosing and producing the best viral vectors to be used for your desired applications can be difficult, but we are here to help every step of the way!
Research / Preclinical Grade